M3-Brigade Acquisition V Corp. (NASDAQ:MBAV – Get Free Report) was the recipient of a significant growth in short interest in February. As of February 27th, there was short interest totaling 131,764 shares, a growth of 304.4% from the February 12th total of 32,579 shares. Approximately 0.4% of the shares of the stock are sold short. Based on an average daily trading volume, of 24,712 shares, the short-interest ratio is presently 5.3 days. Based on an average daily trading volume, of 24,712 shares, the short-interest ratio is presently 5.3 days. Approximately 0.4% of the shares of the stock are sold short.
Insiders Place Their Bets
In other news, major shareholder Fitzgerald & Co. Cantor acquired 3,529,081 shares of M3-Brigade Acquisition V stock in a transaction on Wednesday, December 17th. The stock was bought at an average cost of $10.80 per share, with a total value of $38,114,074.80. Following the completion of the purchase, the insider owned 7,779,865 shares of the company’s stock, valued at $84,022,542. This represents a 83.02% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.
Institutional Investors Weigh In On M3-Brigade Acquisition V
Hedge funds have recently added to or reduced their stakes in the stock. Saba Capital Management L.P. acquired a new stake in shares of M3-Brigade Acquisition V in the fourth quarter valued at approximately $151,000. Hudson Bay Capital Management LP bought a new position in M3-Brigade Acquisition V in the fourth quarter valued at approximately $159,000. Prelude Capital Management LLC acquired a new position in shares of M3-Brigade Acquisition V in the third quarter valued at approximately $281,000. Sandia Investment Management LP bought a new stake in shares of M3-Brigade Acquisition V during the second quarter worth $334,000. Finally, Clear Street LLC lifted its position in M3-Brigade Acquisition V by 2,280.8% in the 2nd quarter. Clear Street LLC now owns 32,069 shares of the company’s stock valued at $362,000 after acquiring an additional 30,722 shares in the last quarter.
M3-Brigade Acquisition V Stock Up 0.0%
Analysts Set New Price Targets
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a report on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.
About M3-Brigade Acquisition V
M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.
The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.
Featured Articles
- Five stocks we like better than M3-Brigade Acquisition V
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for M3-Brigade Acquisition V Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M3-Brigade Acquisition V and related companies with MarketBeat.com's FREE daily email newsletter.
